• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued to demonstrate the powerful disease-modifying effects of BB-301, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback